2018 dates confirmed: 8th & 9th May 2018.

Pre-register now

 

In March 2017 Accelerating Cancer Immunotherapy brought together cutting-edge researchers with frontline clinicians to accelerate knowledge in this fastest moving area of oncology. Operating across two auditoria, the faculty of globally recognised experts detailed their discoveries to a broad audience of healthcare professionals to enable better understanding of the likely upcoming treatment options for their patients.

Delegates from across the globe registered to attend the meeting, travelling from as far afield as Australia, India, the Americas and Europe.

 

The meeting was endorsed and supported by our colleagues at The Lancet and they hosted an exclusive session on Thursday morning Chaired by the Lancet Oncology Deputy Editor, Dr Cassandra Coburn. ACI was been awarded 11 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME)


FEATURED SPEAKERS

Dr James P. Allison
Dr James P. Allison
Department Chair, Department of Immunology,
Division of Basic Science Research,
The University of Texas
MD Anderson Cancer Center,
Houston, TX, USA
Professor Robert Schreiber, PhDProfessor Robert Schreiber, PhD
Alumni Professor, Pathology and Immunology;
Director, Center for Human Immunology and Immunotherapy Programs
Washington University,
St. Louis, MO. USA

Latest News

ACI 2018 dates confirmed

Accelerating Cancer Immunotherapy 2018 will take place in London on 8th & 9th May 2018. Pre-register now to receive full details of the programme when it is released.

ACI 2017 – Registrations are closed

We’re pleased to announce that registrations for ACI 2017 are now closed – the room has reached capacity. We’ll be opening registration for ACI 2018 soon, but in the meantime, to be at the front of the queue for 2018, register your interest here


ACI is supported by sponsorship from the Pharmaceutical Industry.
As support agreements are reached, disclosure of the supporters is listed here.